Skip to content

Healthcare Data News

News from the healthcare data industry

  • Submit News
  • Home
  • Industry News
  • Competitor News
  • Partner and Collaborator News
Healthcare Data News
  • Home
  • Industry News
  • Competitor News
  • Partner and Collaborator News
  • Submit News

Author: admin

Posted on December 10, 2021 Clinical Trials Competitor News Product Updates

TriNetX Launches Diversity Lens Analytic to Improve Access to Clinical Trials for Underrepresented Patient Populations

CAMBRIDGE, Mass., Dec. 9, 2021 /PRNewswire/ — TriNetX, the global network of healthcare organizations driving real-world research to accelerate the development of new therapies, has announced the launch of Diversity Lens, an analytic...

Posted on December 10, 2021 Academic AI Collaborations Oncology Partner and Collaborator News

M2GEN Announces Collaboration with Microsoft to Advance Bioinformatics Solutions for Oncology

TAMPA, Fla., Dec. 9, 2021 /PRNewswire/ — M2GEN, a bioinformatics company accelerating discoveries in oncology research through superior data and analytics, today announced it is partnering with Microsoft to advance and scale...

Posted on December 10, 2021December 13, 2021 Industry News

The future of patient data: 3 pillars of successful analytics implementation

By Joyoti Goswami December 10, 2021 Photo by Westend61/Getty Images In the COVID-19 era, health systems recognize that existing data infrastructure is inadequate. Here are three things large datasets need...

Posted on December 9, 2021January 3, 2022 Fundraising/IPO Partner and Collaborator News

$25 million gift to Brown to accelerate discovery at renamed Legorreta Cancer Center

PROVIDENCE, R.I. [Brown University]  — A $25 million gift from accomplished life sciences entrepreneur and investor Pablo Legorreta and his wife, Almudena, will advance a plan to transform Brown University’s recently...

Posted on December 9, 2021 Competitor News Oncology RWE Study

Tempus Announces Six Abstracts Accepted For Poster Presentation at the 2021 San Antonio Breast Cancer Symposium

CHICAGO–(BUSINESS WIRE)–Tempus, a leader in artificial intelligence and precision medicine, today announced six abstracts accepted for poster sessions at the 2021 San Antonio Breast Cancer Symposium (SABCS) taking place December...

Posted on December 8, 2021 Collaborations Partner and Collaborator News

Babylon and Palantir Make Rapid Progress in Developing One of the World’s Most Advanced Health Data Platforms

DENVER & PALO ALTO, Calif.–(BUSINESS WIRE)–Babylon Holdings Limited (NYSE: BBLN) (“Babylon”) — a world leading company re-engineering how people engage with their health at every step of the care continuum...

Posted on December 8, 2021 Competitor News Government/Regulatory Oncology Product Updates

FoundationOne®CDx Receives FDA Approval as a Companion Diagnostic for BRAF Inhibitor Therapeutics in Melanoma

CAMBRIDGE, Mass.–(BUSINESS WIRE)–Foundation Medicine, Inc. today announced that it has received approval from the U.S. Food and Drug Administration (FDA) for FoundationOne®CDx to be used as a companion diagnostic for two...

Posted on December 8, 2021 Competitor News RWE Study

Radicle Science Releases Initial Findings from Largest Real World Evidence Study Evaluating Effectiveness of CBD Products

December 07, 2021 07:00 AM Eastern Standard Time SAN DIEGO–(BUSINESS WIRE)–Radicle Science, a transformative healthtech B-corp validating natural products for the first time, announces initial findings from the Radicle ACES...

Posted on December 8, 2021 Industry News

Liberating real-world data for use in clinical trials

Liberating the genetics, laboratory and pharmacy data that sits deep within healthcare subsystems, while protecting patient information and navigating the global regulatory landscape, is no easy task but would greatly...

Posted on December 7, 2021 Clinical Trials Collaborations Competitor News International Japan

ASLAN Pharmaceuticals and IQVIA Biotech Enter Into Strategic Collaboration

MENLO PARK, Calif. and SINGAPORE, Dec. 06, 2021 (GLOBE NEWSWIRE) — ASLAN Pharmaceuticals (Nasdaq: ASLN), a clinical-stage, immunology-focused biopharmaceutical company developing innovative treatments to transform the lives of patients, today...

Posts pagination

← 1 … 140 141 142 143 144 … 155 →

  • Search by Keyword

  • Reset Filter
  • Search by Category

  • Search by Company and Location

© 2025 Healthcare Data News / Powered by WordPress / Theme by Design Lab